GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Date Action Amount Person Type
Apr 09, 2024 Buy 2 063 Freeman Kevin D Common Stock
Mar 01, 2024 Sell 152 584 Lewis Joel Common Stock
Jan 24, 2024 Buy 50 000 Zordani Richard A. Jr. Stock Option (right to buy)
Jan 24, 2024 Buy 23 256 Uihlein Richard E Common Stock
Jan 24, 2024 Buy 50 000 Uihlein Richard E Stock Option (right to buy)
Jan 24, 2024 Buy 50 000 Schwartz Elissa J. Stock Option (right to buy)
Jan 24, 2024 Buy 50 000 Rubin Marc Stock Option (right to buy)
Jan 24, 2024 Buy 50 000 Omenn Gilbert S Stock Option (right to buy)
Jan 24, 2024 Buy 91 000 Lewis Joel Stock Option (right to buy)
Jan 24, 2024 Buy 56 000 Lewis Joel Restricted Stock Unit
Jan 24, 2024 Buy 50 000 Freeman Kevin D Stock Option (right to buy)
Jan 24, 2024 Buy 50 000 Eldred Kary Stock Option (right to buy)
Jan 24, 2024 Buy 50 000 Carson Benjamin Sr Stock Option (right to buy)
Jan 24, 2024 Buy 65 000 Callicutt Jack W Stock Option (right to buy)
Jan 24, 2024 Buy 40 000 Callicutt Jack W Restricted Stock Unit
Jan 24, 2024 Buy 65 000 Boudes Pol F Stock Option (right to buy)
Jan 24, 2024 Buy 40 000 Boudes Pol F Restricted Stock Unit
Jan 24, 2024 Buy 50 000 Amelio Gilbert F Stock Option (right to buy)
Jan 16, 2024 Buy 500 Eldred Kary Common Stock
Dec 29, 2023 Buy 11 606 Lewis Joel Common Stock
Dec 15, 2023 Buy 12 042 Lewis Joel Common Stock
Dec 07, 2023 Buy 100 000 Carson Benjamin Sr Common Stock Options
Nov 30, 2023 Buy 9 880 Lewis Joel Common Stock
Nov 15, 2023 Buy 10 303 Lewis Joel Common Stock
Oct 31, 2023 Buy 9 444 Lewis Joel Common Stock
Oct 13, 2023 Buy 9 585 Lewis Joel Common Stock
Oct 13, 2023 Buy 10 035 Lewis Joel Common Stock
Sep 29, 2023 Buy 10 035 Lewis Joel Common Stock
Sep 26, 2023 Buy 200 000 Uihlein Richard E Common Stock
Sep 26, 2023 Buy 200 000 Uihlein Richard E Common Stock
Sep 26, 2023 Buy 200 000 Uihlein Richard E Common Stock
Sep 26, 2023 Buy 170 000 Uihlein Richard E Common Stock
Sep 26, 2023 Buy 1 466 204 Uihlein Richard E Common Stock
Sep 26, 2023 Sell 170 000 Uihlein Richard E Common Stock Purchase Warrant (right to buy)
Sep 26, 2023 Sell 1 466 204 Uihlein Richard E Common Stock Purchase Warrant (right to buy)
Sep 26, 2023 Sell 200 000 Uihlein Richard E Common Stock Purchase Warrant (right to buy)
Sep 26, 2023 Sell 200 000 Uihlein Richard E Common Stock Purchase Warrant (right to buy)
Sep 15, 2023 Buy 10 947 Lewis Joel Common Stock
Aug 31, 2023 Buy 11 010 Lewis Joel Common Stock
Aug 15, 2023 Buy 12 042 Lewis Joel Common Stock
Jul 31, 2023 Buy 12 844 Lewis Joel Common Stock
Jul 19, 2023 Buy 1 598 Eldred Kary Common Stock
Jul 14, 2023 Buy 11 820 Lewis Joel Common Stock
Jun 30, 2023 Buy 13 380 Lewis Joel Common Stock
Jun 15, 2023 Buy 13 196 Lewis Joel Common Stock
May 31, 2023 Buy 12 272 Lewis Joel Common Stock
May 15, 2023 Buy 11 748 Lewis Joel Common Stock
Apr 28, 2023 Buy 10 947 Lewis Joel Common Stock
Apr 14, 2023 Buy 9 585 Lewis Joel Common Stock
Mar 31, 2023 Buy 9 175 Lewis Joel Common Stock
Mar 15, 2023 Buy 10 140 Lewis Joel Common Stock
Mar 01, 2023 Sell 75 529 Lewis Joel Common Stock
Feb 28, 2023 Buy 9 308 Lewis Joel Common Stock
Feb 21, 2023 Buy 1 000 Eldred Kary Common Stock
Feb 16, 2023 Buy 1 000 Lewis Joel Common Stock
Feb 15, 2023 Buy 13 380 Lewis Joel Common Stock
Feb 07, 2023 Buy 143 836 Lewis Joel Common Stock
Jan 31, 2023 Buy 15 086 Lewis Joel Common Stock
Jan 26, 2023 Buy 40 000 Zordani Richard A. Jr. Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Shlevin Harold H. Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Schwartz Elissa J. Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Rubin Marc Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Omenn Gilbert S Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Freeman Kevin D Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Eldred Kary Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Amelio Gilbert F Stock Option (right to buy)
Jan 26, 2023 Buy 50 000 Callicutt Jack W Stock Option (right to buy)
Jan 26, 2023 Buy 50 000 Boudes Pol F Stock Option (right to buy)
Jan 26, 2023 Buy 70 000 Lewis Joel Stock Option (right to buy)
Jan 26, 2023 Buy 40 000 Czirr James C Stock Option (right to buy)
Jan 26, 2023 Buy 36 036 Uihlein Richard E Common Stock
Jan 26, 2023 Buy 40 000 Uihlein Richard E Stock Option (right to buy)
Jan 25, 2023 Buy 1 300 Eldred Kary Common Stock
Jan 13, 2023 Buy 15 351 Lewis Joel Common Stock
Dec 31, 2022 Buy 0 10x Fund, L.p.
Dec 30, 2022 Buy 15 487 Lewis Joel Common Stock
Dec 21, 2022 Sell 0 10x Fund, L.p. Common Stock
Dec 21, 2022 Sell 0 10x Fund, L.p. Common Stock
Dec 21, 2022 Sell 0 10x Fund, L.p. Common Stock
Dec 21, 2022 Sell 0 10x Fund, L.p. Common Stock
Dec 15, 2022 Buy 15 086 Lewis Joel Common Stock
Nov 30, 2022 Buy 13 780 Lewis Joel Common Stock
Nov 17, 2022 Buy 4 000 Callicutt Jack W Common Stock
Nov 15, 2022 Buy 14 113 Lewis Joel Common Stock
Oct 31, 2022 Buy 12 681 Lewis Joel Common Stock
Oct 28, 2022 Buy 10 000 Freeman Kevin D Common Stock
Oct 14, 2022 Buy 10 802 Lewis Joel Common Stock
Sep 30, 2022 Buy 10 736 Lewis Joel Common Stock
Sep 30, 2022 Buy 10 736 Lewis Joel Common Stock
Sep 15, 2022 Buy 9 777 Lewis Joel Common Stock
Aug 31, 2022 Buy 9 211 Lewis Joel Common Stock
Aug 15, 2022 Buy 8 028 Lewis Joel Common Stock
Jul 29, 2022 Sell 0 10x Fund, L.p. Common Stock
Jul 29, 2022 Sell 0 10x Fund, L.p. Common Stock
Jul 29, 2022 Buy 7 743 Lewis Joel Common Stock
Jul 29, 2022 Buy 10 606 Lewis Joel Common Stock
Jul 27, 2022 Sell 10 000 10x Fund, L.p. Common Stock
Jul 22, 2022 Sell 10 000 Czirr James C Common Stock
Jul 22, 2022 Sell 10 000 10x Fund, L.p. Common Stock
Jan 12, 2022 Buy 0 Czirr James C
INSIDER POWER
27.876
Last 100 transactions
Buy: 4 371 740 | Sell: 2 294 317 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 27.876.

In total, the insiders bought 4 371 740 and sold 2 294 317 GALT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT